Summary
- Identified by researchers at the Université de Montréal's IRCM.
- Molecules show up to 25 times stronger activity against Ebola and SARS-CoV-2.
- Potential implications for developing new antiviral treatments.
Key Facts
| Fact | Value |
|---|---|
| Research Institution | Université de Montréal's Montreal Clinical Research Institute |
| Activity Strength | Up to 25 times stronger against Ebola and COVID-19 |
Updates
- No subsequent updates recorded.